#ChatsWithChaudhrey the Podcast

 I caught up with Annabel this week as part of my #ReflectionsandForecasts,series. We discussed #Tio2, #supplychain, #forecasting,  #drugsecurity, #wellness and more.

I asked Annabel....

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 

• Can you give me a quick overview of Colorcon? 00:44

• One word to describe 2022 and why? 01:05

• What were some of Colorcon’s achievements in 2022? 02:07

• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:09

• How did Colorcon overcome the challenges around Supply Chain? 03:52

• Are there any areas you think the industry could improve? 04:29

2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬

• What are your predictions for #Pharma in 2023? 05:17

• What developments and trends do you expect to see/predict in #TabletCoatings and #DrugSecurity, and what can we expect from Colorcon in 2023? 06:12

• Finally, what last thoughts would you like to leave viewers with for 2023? 07:07

If you have any questions for Annabel please leave them below in the comments.

🎞 Watch  the interview here https://lnkd.in/eVM_YCuR

You can find out more about #Colorcon and their solutions at www.colorcon.com

I sat down with Julie Waras Brogren. Deputy CEO for Biotech Ascelia Pharma as part of my #ReflectionsandForecast20222023 interview series.

I asked Julie...

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
✺ For those who are not familiar, please give us a quick introduction to you and Ascelia Pharma. 01:05
✺ In what way is your technology innovative and how does it differ from other products on the market? 02:22
✺ What is Orviglance and what stage are you currently at with Orviglance? 05:01
✺ One word to describe 2022 and why? 05:23
✺ What were some of company's key achievements in 2022? 06:18
✺ Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? Are there any trends and challenges you are noticing as an emerging biotech company? 07:54
✺ Has it been difficult to get investment for non-covid related #drugdevelopment? 09:35
✺ Is Ascelia’s #ClinicalTrials program global and was it impacted by #Covid? 10:17
✺ Are there any areas you think the industry could improve? 11:33

2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬
✺ What are your predictions for #LifeScience/ #Pharma/ #BioPharma in 2023? 12:57
✺ What developments and trends do you expect to see/predict in #orphanoncology treatments? 14:42
✺Lets look more specifically at Ascelia in 2023 and beyond. As a #biotech with a developing portfolio, where is your focus, what are your 2-3 year objectives? 17:22
✺ In terms of the future, what partnerships and collaborations would be ideal for advancing the company’s growth? 19:14
✺ Finally, what last thoughts would you like to leave viewers with for 2023? 22:09

Feel free to leave any questions or comments for Julie below.

🎞 You can WATCH the interview here https://lnkd.in/enT7WtC3

You can learn more about #AsceliaPharma at www.Ascelia.com

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬
• Can you give me a quick overview of ApiJect? 00:512
• What were some of ApiJect achievements in 2022? 03:21
• One word to describe 2022 and why? 05:33
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:44
• Are there any areas you think the industry could improve? 09:06

2023 Forecasts
• What are your predictions for BioPharma/ Pharma in 2023? 10:36
• What developments and trends do you expect to see/predict in the use of Blow Fill seal and Drug delivery for Vaccines, and what can we expect from ApiJect in 2023? 16:20
• Finally, what last thoughts would you like to leave viewers with for 2023? 18:30

🎞 Watch the interview here https://lnkd.in/ew6cdqPf

You can learn more about ApiJect by visiting www.Apiject.com


This post is sponsored by ApiJect

I was delighted to catch up with Cherwell Laboratories MD Andy Whittard as part of this years #RefelectionsandForecasts interview series.

We talked about Cherwell Laboratories, their achievements in 2022,  their "Delivery Knowledge" platform, meeting the challenges in 2022, the impact of #Annex1 on #EnviromentalMonitoring, #ContinuousMonitoring, #supplychain, co-operation, and sustainability.

2022 Reflections 

• Can you give me a quick overview of Cherwell Laboratories? 00:39

• One word to describe 2022 and why? 01;50

• What were some of Cherwell Laboratories key achievements in 2022? 04:40

• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:29

• How have Cherwell managed customers expectations due to the challenges around Supply Chain issues? 08:03

• Did Andy think that dealing with the Covid19 period helped the business become more "agile"? 09:33

•  When Annex 1 came out in August was it what Andy expected it to be? 11:33

• Are there any areas you think the industry could improve? 13:13

 2023 Forecasts

• What are your predictions for the Life Science/Pharma/ BioPharma in 2023? 15:14

• What developments and trends do you expect to see/predict in contamination control with the new Annex One Updates? 17:49

• Where does  Andy think AI and Machine learning can help in Environmental Monitoring?24:14 

• What can we expect from Cherwell Laboratories 2023? 25:52

• Finally, what last thoughts would you like to leave viewers with for 2023? 29:09

You can check out #Cherwells  online EU #GMP and #Annex resources page which provides further background and insight on the latest regulatory update governing the manufacture of #sterile #medicinalproducts, at https://lnkd.in/geW5f2EV

and learn more about Cherwell Laboratories at www.cherwell-labs.co.uk

You can WATCH the interview here https://lnkd.in/ecsqJjK6

Here's Episode 2 of #ReflectionandForecasts2223 series with my good friend Oliver Stauffer CEO of #PTI

We spoke about the impact of #ATMPs and #Biologics on #ClosedContainerIntegrity Testing, The growth of #CDMO's, #SupplyChain, #AI, #MachineLearning, #Automation, #Collaboration, #Annex1 and more.

I asked Oliver...

2022 Reflections
• Can you give me a quick overview of #PTI? 00:46
• One word to describe 2022 and why? 01:32
• What were some of PTI key achievements in 2022? 02:50
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:59
• How have the growth of the Biologics and ATMP impacted the technologies required for #CCIT? 05:53
• Are there any areas you think the industry could improve? 07:25

2023 Forecasts
• What are your predictions for #Pharma/ #BioPharma in 2023? 08:26
• Did Oliver think the trends in 2023, would be different for North America and Europe due to Annex 1? 9.29
• What developments and trends do you expect to see in #CCITesting and the impact Annex 1 will have in that area? 11:53
• What role will AI and Machine Learning impact on #CCIT? 13:17
• Does Oliver think collaborations will continue in the industry? 14:38
• What can we expect from PTI in 2023? 16:57
• Finally, what last thoughts would you like to leave viewers with for 2023? 18:26

I am delighted to be kicking off this years #ReflectionsandForcasts series with Carsten Press SVP Key Account Management, Supply Chain and Marketing, CDMO #VetterPharma

We had a really interesting discussion covering #Sustainability, #Robotics, the role of #CDMO's, #SupplyChainSecurity, #collaboration, and more.

I asked Carsten...

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 

✹ Can you give me an overview of yourself and your role at Vetter Pharma? 00:58

✹ Can you give me a quick overview of Vetter Pharma? 01:45

✹ One word to describe 2022 and why? 03:13

✹ How has Vetter changed since the pandemic? 03:51

✹ What were some of Vetter's key achievements in 2022? 05:12

✹ Looking back at 2022 what industry trends, stood out for you? 07:03

✹ Has the role of CDMO's changed over the past few years? 08:26

✹ Are there any areas you think the industry could improve? 10:34

✹ What has driven Pharma's large carbon footprint? 11:20

2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬

✹ What are your predictions for the #LifeScience/#Parma sector in 2023? 12:17

✹ What developments and trends do you expect to see/predict in the area of Pharma manufacturing? 13:34

✹ How have Vetter ensured #securityofsupply? 15:18

✹ What is the alliance with Rentschler Biopharma SE, how is it going to work, and does Carsten believe that collaboration with other companies is the way forward in Pharma? 18:20

✹ What can we expect from Vetter Pharma in 2023? 21:39

✹ Finally, what last thoughts would you like to leave viewers with for 2023? 23:01

You can see  Vetter Pharma  sustainability report here

https://lnkd.in/ea89cRXw

nd learn more about Vetter Pharma here https://lnkd.in/eeGkdGPf

#RSKVetterPharma #ReflectionsandForecasts20222023

#DrugDiscoverytoDrugDelivery, #Pharma , #Biopharma , #Biotech, 

#ClinicalManufacturing #DrugManufacturing #PharmaManufacturing

You can watch the video version of this interview here  https://lnkd.in/eUzzs-HV

I sat down with Jane, who is Country Manager for #PharmaLexIreland to get her thoughts on 2021 and predictions for 2022.

I asked her....

• Give me a quick overview of #PharmaLex and her role? 00:33

• What does a Country Manager do? 01:19

• For one word to describe 2021 and why? 01:54

• How did the pandemic impact the business in 2021? 02:49

• What were some of the key business achievements for that stood out for her?  04:29

• Looking back at 2021 what developments, stories and trends stood out for her? 05:36

• Are there any areas Jane think the industry could have done better and how? 06:41

• What are Jane's predictions for the Pharma in 2022 ? 7:46

• How has #Ireland developed into a hub for BioPharma in Europe? 09:00

• What new developments and changes, if any, could Jane  see around regulations with Pharma? 10:48

• What is the EC Review? 11:12

• How does the UK being out o the UK impact regulatory changes? 11:45

• What opportunities does Jane see for companies in 2022?  12:41

• What can we expect from PharmaLex in 2022? 13:25

• What does Jane think is the most important element in developing a great #companyculture to get the most out of people? 14:07

• Finally, what last thoughts Jane would like to leave with viewers for 2022? 15:23

You can WATCH the interview here https://lnkd.in/dQrS69KP

You can find out more about PharmaLex Ireland at https://lnkd.in/dt_Fi9Vn

S𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 here https://lnkd.in/gdthyRu to my YouTube channel 𝐑𝐒𝐊-𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐌𝐞𝐝𝐢𝐚 and view over 350 interviews and demos, and learn from experts across #LifeScience, #Pharma and  #BioPharma covering everything from #DrugDiscovery to #DrugDevelopment to #DrugManufacturing to #DrugDelivery and all things in between!

#ConnectingandInforming #DrugDiscoverytoDrugDelivery
#RSKPharmaLex #pharma, #compliance, #regulations, #pharmaceuticals, #biotech, #biopharma, #drugdevelopment,

🎞 S03 E09 #ChatsWithChaudhrey with Cambridge Design Partnership's, Clare Beddoes on challenges and opportunities in #drugdelivery 18th Jan 2022

I caught up with Clare, who is a Senior Medical Innovation and Research Consultant, at  #CambridgeDesignPartnership to learn more about the current challenges and future opportunities in drug delivery.

I asked Clare..

•  For a an overview of CDP and her own role? 01:02

•  What do we actually mean by drug delivery and what forms does that take? 03:00

•  What keeps formulation and device teams up at night? 03:59

•  Improving customer experience is a huge driver within the consumer space. Are pharma companies doing likewise for #patientexperience , whether that's physical or digital experiences – what has Clare seen happen in this space recently? 05:58

•  Is #PatientCompliance one of the areas that Digital has helped?

Where exactly should digital technologies be introduced into drug delivery in order to benefit patients? 08:12

•  What will be the long-term impact of the pandemic on the drug delivery industry? 12:52

•  What does Clare see as the big trends in the #drugdelivery space in 2022? 15:24

•  What can we expect from CDP this year? 16:26

You can watch the video of  this interview here https://lnkd.in/eUjHUMNx

You can also find out more at www.cambridge-design.com

𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 here https://lnkd.in/gdthyRu to my YouTube channel 𝐑𝐒𝐊-𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐌𝐞𝐝𝐢𝐚 and view over 350 interviews and demos, and learn from experts across #LifeScience, #Pharma and  #BioPharma covering everything from #DrugDiscovery to #DrugDevelopment to #DrugManufacturing to #DrugDelivery and all things in between!

#RSKCDP #MedicalDevices #Wearables #DigitalHealth #ConnectedDevices #PFS 

I sat down in January with RSSL’s Jamie Tempest, Senior Scientist 1, and Thomas Gosling ,Scientist 2 to learn more about #SterilityTesting
I asked them....
• For a quick overview of RSSL and their roles? 00:56
• What is sterility testing and why is sterility testing important? 02:34
• What are the regulations around Sterility testing and how does #RSSL ensure they comply? 04:12
• Describe how the sterility testing Lab is set up? 05:50
• What are the key considerations and things to watch out for when choosing a sterility service provider? 07:43
• To give me some examples of sort of challenges they meet when carrying out Sterility Testing? 09:27
• Are there any samples that are a bit of a nightmare to work with and how do they get around that? 12:12
• How can RSSL help improve testing methods and are there any tips they could offer? 14:28
• Where can people find out more? 16:15

You can watch this interview and also view other #ChatsWithChaudhrey I have done with the experts at RSSL on a range of topics by visiting the 𝐑𝐒𝐒𝐋 𝐩𝐥𝐚𝐲𝐥𝐢𝐬𝐭 on my 𝐘𝐨𝐮𝐓𝐮𝐛𝐞 𝐂𝐡𝐚𝐧𝐧𝐞𝐥, 𝐑𝐒𝐊 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐌𝐞𝐝𝐢𝐚 here https://lnkd.in/gHR86ia

Visit www.RSSL.com to learn more about their services and training courses.

𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 here https://lnkd.in/gdthyRu to my YouTube channel 𝐑𝐒𝐊-𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐌𝐞𝐝𝐢𝐚 and view over 350 interviews and demos, and learn from experts across #LifeScience, #Pharma and  #BioPharma covering everything from #DrugDiscovery to #DrugDevelopment to #DrugManufacturing to #DrugDelivery and all things in between!

#ConnectingandInforming #DrugDiscoverytoDrugDelivery
#methoddevelopment, #RSKRSSL , #testingservices

I sat down with Jonathan in January  as part of my #ReflectionsAndForecasts 2021/22 series and we covered a lot, including what's the most important thing to have a successful company culture, check it out and please leave any comments and questions below the video.
I asked Jonathan....
• To give me a quick overview of #BioWorksTechnologies? 00:49
• A lot of companies offer similar products, what´s special about Bio-Works? 01:46
• Describe 2021 in one word and why? 02:56
• What had driven Bio-Works over the past 24 months? 04:07
• Has the #supplychain impacted business? 06:12
• How has the #pandemic impacted the business in Year 2? 07:45
• What were some of BIO-WORKS the achievements in 2021? 09:43
• What is the main thing as part of the company's culture that has helped drive the business?10;39
• Jonathan said he would rather talk about the future than the past year, why is that? 12:20
• What are his predictions for the #LifeScience/#Pharma sector in 2022? 13:00
• What risks are out there that may impact the business? 16:38
• And what are the opportunities for next year for Bio-Works 18:26
• What can we expect to see from Bio-Works in 2022? 20:46
• How will the company maintain their existing relationships with their customer as the company grows? 23:20
• Last thoughts for viewers for 2022? 25:06

You can WATCH this and other Bio-Works interviews here https://www.youtube.com/playlist?list=PLFj-EpegwkMANmwxpgckGrIaEA5-3pxta

You can find out more about Bio-Works and their solutions here
www.bio-works.com
https://lnkd.in/g7kCTkE

#chromatography, #purification, #peptides, #RSKBW, #Resins, #Biopharma, #Resins

𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 here https://lnkd.in/gdthyRu to my YouTube channel 𝐑𝐒𝐊-𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐌𝐞𝐝𝐢𝐚 and view over 350 interviews and demos, and learn from experts across #LifeS